M. Machwate

1.0k total citations
14 papers, 865 citations indexed

About

M. Machwate is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, M. Machwate has authored 14 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in M. Machwate's work include Bone Metabolism and Diseases (6 papers), Bone health and treatments (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). M. Machwate is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Bone health and treatments (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). M. Machwate collaborates with scholars based in France, United States and Israel. M. Machwate's co-authors include Gideon A. Rodan, Pierre J. Marie, Xavier Holy, E. Zérath, Le T. Duong, Päivi T. Lakkakorpi, I. Nakamura, Rose Marie Nagy, Sevgi B. Rodan and Satoru Harada and has published in prestigious journals such as Journal of Clinical Investigation, Endocrinology and Molecular Pharmacology.

In The Last Decade

M. Machwate

13 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Machwate France	13	526	273	169	152	114	14	865
D L Goad United States	10	543 1.0×	253 0.9×	63 0.4×	79 0.5×	112 1.0×	11	832
Weiguang Zhao United States	11	1.1k 2.1×	418 1.5×	186 1.1×	176 1.2×	313 2.7×	15	1.7k
Isao Inoki Japan	13	862 1.6×	192 0.7×	28 0.2×	74 0.5×	96 0.8×	19	1.4k
Helmut Glantschnig Austria	15	652 1.2×	367 1.3×	181 1.1×	30 0.2×	114 1.0×	32	1.1k
Shibing Yu United States	17	601 1.1×	275 1.0×	71 0.4×	20 0.1×	89 0.8×	25	965
May Kung Sutherland United States	18	551 1.0×	520 1.9×	139 0.8×	34 0.2×	176 1.5×	33	1.2k
Kent Z.Q. Wang United States	12	746 1.4×	335 1.2×	58 0.3×	73 0.5×	32 0.3×	15	960
Merrilee R. Flannery United States	13	636 1.2×	242 0.9×	73 0.4×	39 0.3×	39 0.3×	14	801
Dorothy Hu United States	16	801 1.5×	366 1.3×	157 0.9×	18 0.1×	180 1.6×	26	1.2k
John Paul Kirton United Kingdom	10	522 1.0×	107 0.4×	26 0.2×	28 0.2×	92 0.8×	10	1.0k

Countries citing papers authored by M. Machwate

Since Specialization

Citations

This map shows the geographic impact of M. Machwate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Machwate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Machwate more than expected).

Fields of papers citing papers by M. Machwate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Machwate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Machwate. The network helps show where M. Machwate may publish in the future.

Co-authorship network of co-authors of M. Machwate

This figure shows the co-authorship network connecting the top 25 collaborators of M. Machwate. A scholar is included among the top collaborators of M. Machwate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Machwate. M. Machwate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Weinreb, Miron, et al.. (2006). Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity. Prostaglandins Leukotrienes and Essential Fatty Acids. 75(2). 81–90. 36 indexed citations

Weinreb, Miron, et al.. (2001). Expression of the prostaglandin E2 (PGE2) receptor subtype EP4 and its regulation by PGE2 in osteoblastic cell lines and adult rat bone tissue11M.W. and M.M. contributed equally to this study.. Bone. 28(3). 275–281. 47 indexed citations

Machwate, M., Satoru Harada, Chih‐Tai Leu, et al.. (2001). Prostaglandin Receptor EP4 Mediates the Bone Anabolic Effects of PGE2. Molecular Pharmacology. 60(1). 36–41. 17 indexed citations

Machwate, M., Satoru Harada, Chih‐Tai Leu, et al.. (2001). Prostaglandin Receptor EP₄ Mediates the Bone Anabolic Effects of PGE₂. Molecular Pharmacology. 60(1). 36–41. 144 indexed citations

Machwate, M., Sevgi B. Rodan, Gideon A. Rodan, & Shun-ichi Harada. (1998). Sphingosine Kinase Mediates Cyclic AMP Suppression of Apoptosis in Rat Periosteal Cells. Molecular Pharmacology. 54(1). 70–77. 52 indexed citations

Duong, Le T., Päivi T. Lakkakorpi, I. Nakamura, et al.. (1998). PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.. Journal of Clinical Investigation. 102(5). 881–892. 213 indexed citations

Zérath, E., Xavier Holy, M. Machwate, et al.. (1997). TGF-β2 prevents the impaired chondrocyte proliferation induced by unloading in growth plates of young rats. Life Sciences. 61(24). 2397–2406. 19 indexed citations

Machwate, M., E. Zérath, Xavier Holy, et al.. (1995). Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia induced by unloading in rats.. Journal of Clinical Investigation. 96(3). 1245–1253. 56 indexed citations

Machwate, M., Amandine Jullienne, M.S. Moukhtar, & Pierre J. Marie. (1995). Temporal variation of c‐fos proto‐oncogene expression during osteoblast differentiation and osteogenesis in developing rat bone. Journal of Cellular Biochemistry. 57(1). 62–70. 43 indexed citations

10.

Zérath, E., M. Machwate, Xavier Holy, et al.. (1995). Transforming growth factor-β2 systemic administration prevents the decrease in proliferative zone of growth cartilage in unloaded rats. Bone. 17(6). 596–596. 1 indexed citations

11.

Machwate, M., Amandine Jullienne, M.S. Moukhtar, Abderrahim Lomri, & Pierre J. Marie. (1995). c-fos protooncogene is involved in the mitogenic effect of transforming growth factor-beta in osteoblastic cells.. Molecular Endocrinology. 9(2). 187–198. 38 indexed citations

12.

Machwate, M., E. Zérath, Xavier Holy, Philippe Pastoureau, & Pierre J. Marie. (1994). Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats.. Endocrinology. 134(3). 1031–1038. 109 indexed citations

13.

Machwate, M.. (1994). Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats. Endocrinology. 134(3). 1031–1038. 25 indexed citations

14.

Machwate, M., E. Zérath, Xavier Holy, et al.. (1993). Skeletal unloading in rat decreases proliferation of rat bone and marrow-derived osteoblastic cells. American Journal of Physiology-Endocrinology and Metabolism. 264(5). E790–E799. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact